Aphelion Capital led the round with participation from existing and new investors including Elliott Management, the University of Chicago, M25 Group, and the Harvard Business School Angels of Chicago. In conjunction with the financing Ned Scheetz, Anne Sissel, Immanuel Thangaraj, and Kurt Azarbarzin will be joining the Board of Directors.
“I’ve seen the traditional solutions for managing the OR fall short for years. The proliferation of new devices and tools adds additional layers of difficulty for surgical teams. As clinical protocols become more complex, it is critical to coordinate teams around best practices,” said Ned Scheetz, managing partner of Aphelion Capital.
